Treace(TMCI) - 2024 Q3 - Quarterly Results

Exhibit 99.1 Treace Medical Concepts Reports Third Quarter 2024 Financial Results PONTE VEDRA, Fla. – November 5, 2024 – Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship Lapiplasty® and Adductoplasty ® Procedures, today reported financial results for the third quarter ended September 30, 2024. Recent Highlights • Revenue of $45.1 millio ...